(Q35022906)

5 August 2017

1 reference

title

Vascular growth factors for coronary angiogenesis (English)

1 reference

5 August 2017

Chi Hang Lee

1

1 reference

5 August 2017

Pieter C Smits

series ordinal

2

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Journal of Interventional Cardiology

5 August 2017

published in

1 reference

5 August 2017

volume

15

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

511-518

1 reference

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Fibroblast growth factors: at the heart of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Controlled and modulated release of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01097.X

10.1111/J.1540-8183.2002.TB01097.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference